Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06519955Phase 2Recruiting

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

Role: lead

NCT04039386Not ApplicableNot Yet Recruiting

Psychosocial Interventions for Young Adults With Hip Pain

Role: lead

NCT06050668Phase 2Recruiting

Essential Amino Acid Supplementation for Femoral Fragility Fractures

Role: lead

NCT03658278Not ApplicableCompleted

Trauma Screening and Supplementation

Role: lead

All 4 trials loaded